The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains

Detalhes bibliográficos
Autor(a) principal: Nico, Dirlei
Data de Publicação: 2012
Outros Autores: Borges, Ricardo Moreira, Brandao, Layza Mendes, Feijo, Daniel Ferreira, Gomes, Daniele Crespo, Palatnik, Marcos, Rodrigues, Mauricio Martins [UNIFESP], Ribeiro da Silva, Antonio Jorge, Palatnik-de-Sousa, Clarisa Beatriz
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1016/j.vaccine.2012.03.006
http://repositorio.unifesp.br/handle/11600/34887
Resumo: The saponins of Chiococca alba are triterpene bidesmosides that contain glycidic moieties attached to the C-3 and C-28 carbon of their aglycone. We describe that their adjuvant potential increases in direct relationship to the length and hydrophilicity of the C-28 attached sugar chain which contains: arabinose-rhamnose in the CA2, arabinose-rhamnose-xylose in the CA3X; arabinose-rhamnose-apiose in the CA3 and arabinose-rhamnose-apiose-apiose in the CA4 saponin. the hydrophile/lipophile balance calculated for CA2 was 12.7, for CA3 and CA3X was 15.8 and for CA4 19.9. All saponins were formulated with the FML antigen for mice prophylaxis against visceral leishmaniasis. the immune response was studied using an ELISA-antibody assay and monitoring of the intradermal response (IDR) to Leishmania antigens, the cytokine expression in supernatants and the intracellular staining of in vitro cultured splenocytes. After challenge, significant increases of IgG and IgG2a antibodies were noted only in the CA4 vaccinated mice that showed extended IDR, higher IFN-gamma production by CD8+ and TNF-alpha production by CD4+ T cells, higher TNF-alpha secretion and the highest reduction of the parasite load (78%). the increases in IDR, CD4-TNF-alpha,CD8-IFN-gamma and CD8-TNF-alpha by the CA4 vaccine were strong correlates of protection and were significantly correlated to the decrease of parasite load (p=-0.007). Protection generated by the CA4 vaccine was mainly mediated by a CD4+ T cell and a TNF-alpha driven response with a lower contribution of CD8+ T cells, as confirmed by an in vivo depletion with monoclonal antibodies and by vaccination assays in TNF-alpha-receptor knock-out mice. Our results confirm that the superiority of the CA4 saponin is related to the higher hydrophilicity of its longer carbohydrate chain. C. alba saponins were non-toxic and only the xylose-containing saponin CA3X was hemolytic (HD50 = 87 mu g/ml). the increase in sugar units of the saponins is positively correlated to the increase of IDR and to the decrease of parasite load. (C) 2012 Elsevier B.V. All rights reserved.
id UFSP_ee0e7ae595ba9a7878dccc38eb9232a6
oai_identifier_str oai:repositorio.unifesp.br/:11600/34887
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chainsSaponinsAdjuvantsQS21 saponinChiococca albaVisceral leishmaniasisFML antigenThe saponins of Chiococca alba are triterpene bidesmosides that contain glycidic moieties attached to the C-3 and C-28 carbon of their aglycone. We describe that their adjuvant potential increases in direct relationship to the length and hydrophilicity of the C-28 attached sugar chain which contains: arabinose-rhamnose in the CA2, arabinose-rhamnose-xylose in the CA3X; arabinose-rhamnose-apiose in the CA3 and arabinose-rhamnose-apiose-apiose in the CA4 saponin. the hydrophile/lipophile balance calculated for CA2 was 12.7, for CA3 and CA3X was 15.8 and for CA4 19.9. All saponins were formulated with the FML antigen for mice prophylaxis against visceral leishmaniasis. the immune response was studied using an ELISA-antibody assay and monitoring of the intradermal response (IDR) to Leishmania antigens, the cytokine expression in supernatants and the intracellular staining of in vitro cultured splenocytes. After challenge, significant increases of IgG and IgG2a antibodies were noted only in the CA4 vaccinated mice that showed extended IDR, higher IFN-gamma production by CD8+ and TNF-alpha production by CD4+ T cells, higher TNF-alpha secretion and the highest reduction of the parasite load (78%). the increases in IDR, CD4-TNF-alpha,CD8-IFN-gamma and CD8-TNF-alpha by the CA4 vaccine were strong correlates of protection and were significantly correlated to the decrease of parasite load (p=-0.007). Protection generated by the CA4 vaccine was mainly mediated by a CD4+ T cell and a TNF-alpha driven response with a lower contribution of CD8+ T cells, as confirmed by an in vivo depletion with monoclonal antibodies and by vaccination assays in TNF-alpha-receptor knock-out mice. Our results confirm that the superiority of the CA4 saponin is related to the higher hydrophilicity of its longer carbohydrate chain. C. alba saponins were non-toxic and only the xylose-containing saponin CA3X was hemolytic (HD50 = 87 mu g/ml). the increase in sugar units of the saponins is positively correlated to the increase of IDR and to the decrease of parasite load. (C) 2012 Elsevier B.V. All rights reserved.Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, CCS, Ilha Fundao,Dept Microbiol Geral, BR-21941902 Rio de Janeiro, BrazilUniv Fed Rio de Janeiro, Nucleo Pesquisas Prod Nat, BR-21941902 Rio de Janeiro, BrazilUFRJ, Hosp Univ Clementino Fraga Filho, Fac Med, BR-21941913 Rio de Janeiro, BrazilUniversidade Federal de São Paulo UNIFESP, Ctr Interdisciplinar Terapia Genica, BR-04044010 São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Ctr Interdisciplinar Terapia Genica, BR-04044010 São Paulo, BrazilWeb of ScienceConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)CNPq: 500992/2008-8FAPERJ: E-26/110305/2007FAPERJ: E-26/110132/2007FAPERJ: E-26/100416/2007FAPERJ: E-22/102733/2008Elsevier B.V.Universidade Federal do Rio de Janeiro (UFRJ)Universidade Federal de São Paulo (UNIFESP)Nico, DirleiBorges, Ricardo MoreiraBrandao, Layza MendesFeijo, Daniel FerreiraGomes, Daniele CrespoPalatnik, MarcosRodrigues, Mauricio Martins [UNIFESP]Ribeiro da Silva, Antonio JorgePalatnik-de-Sousa, Clarisa Beatriz2016-01-24T14:27:14Z2016-01-24T14:27:14Z2012-05-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion3169-3179application/pdfhttp://dx.doi.org/10.1016/j.vaccine.2012.03.006Vaccine. Oxford: Elsevier B.V., v. 30, n. 21, p. 3169-3179, 2012.10.1016/j.vaccine.2012.03.006WOS000303302900005.pdf0264-410Xhttp://repositorio.unifesp.br/handle/11600/34887WOS:000303302900005engVaccineinfo:eu-repo/semantics/openAccesshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-08T12:11:23Zoai:repositorio.unifesp.br/:11600/34887Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-08T12:11:23Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains
title The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains
spellingShingle The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains
Nico, Dirlei
Saponins
Adjuvants
QS21 saponin
Chiococca alba
Visceral leishmaniasis
FML antigen
title_short The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains
title_full The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains
title_fullStr The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains
title_full_unstemmed The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains
title_sort The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains
author Nico, Dirlei
author_facet Nico, Dirlei
Borges, Ricardo Moreira
Brandao, Layza Mendes
Feijo, Daniel Ferreira
Gomes, Daniele Crespo
Palatnik, Marcos
Rodrigues, Mauricio Martins [UNIFESP]
Ribeiro da Silva, Antonio Jorge
Palatnik-de-Sousa, Clarisa Beatriz
author_role author
author2 Borges, Ricardo Moreira
Brandao, Layza Mendes
Feijo, Daniel Ferreira
Gomes, Daniele Crespo
Palatnik, Marcos
Rodrigues, Mauricio Martins [UNIFESP]
Ribeiro da Silva, Antonio Jorge
Palatnik-de-Sousa, Clarisa Beatriz
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal do Rio de Janeiro (UFRJ)
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Nico, Dirlei
Borges, Ricardo Moreira
Brandao, Layza Mendes
Feijo, Daniel Ferreira
Gomes, Daniele Crespo
Palatnik, Marcos
Rodrigues, Mauricio Martins [UNIFESP]
Ribeiro da Silva, Antonio Jorge
Palatnik-de-Sousa, Clarisa Beatriz
dc.subject.por.fl_str_mv Saponins
Adjuvants
QS21 saponin
Chiococca alba
Visceral leishmaniasis
FML antigen
topic Saponins
Adjuvants
QS21 saponin
Chiococca alba
Visceral leishmaniasis
FML antigen
description The saponins of Chiococca alba are triterpene bidesmosides that contain glycidic moieties attached to the C-3 and C-28 carbon of their aglycone. We describe that their adjuvant potential increases in direct relationship to the length and hydrophilicity of the C-28 attached sugar chain which contains: arabinose-rhamnose in the CA2, arabinose-rhamnose-xylose in the CA3X; arabinose-rhamnose-apiose in the CA3 and arabinose-rhamnose-apiose-apiose in the CA4 saponin. the hydrophile/lipophile balance calculated for CA2 was 12.7, for CA3 and CA3X was 15.8 and for CA4 19.9. All saponins were formulated with the FML antigen for mice prophylaxis against visceral leishmaniasis. the immune response was studied using an ELISA-antibody assay and monitoring of the intradermal response (IDR) to Leishmania antigens, the cytokine expression in supernatants and the intracellular staining of in vitro cultured splenocytes. After challenge, significant increases of IgG and IgG2a antibodies were noted only in the CA4 vaccinated mice that showed extended IDR, higher IFN-gamma production by CD8+ and TNF-alpha production by CD4+ T cells, higher TNF-alpha secretion and the highest reduction of the parasite load (78%). the increases in IDR, CD4-TNF-alpha,CD8-IFN-gamma and CD8-TNF-alpha by the CA4 vaccine were strong correlates of protection and were significantly correlated to the decrease of parasite load (p=-0.007). Protection generated by the CA4 vaccine was mainly mediated by a CD4+ T cell and a TNF-alpha driven response with a lower contribution of CD8+ T cells, as confirmed by an in vivo depletion with monoclonal antibodies and by vaccination assays in TNF-alpha-receptor knock-out mice. Our results confirm that the superiority of the CA4 saponin is related to the higher hydrophilicity of its longer carbohydrate chain. C. alba saponins were non-toxic and only the xylose-containing saponin CA3X was hemolytic (HD50 = 87 mu g/ml). the increase in sugar units of the saponins is positively correlated to the increase of IDR and to the decrease of parasite load. (C) 2012 Elsevier B.V. All rights reserved.
publishDate 2012
dc.date.none.fl_str_mv 2012-05-02
2016-01-24T14:27:14Z
2016-01-24T14:27:14Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.vaccine.2012.03.006
Vaccine. Oxford: Elsevier B.V., v. 30, n. 21, p. 3169-3179, 2012.
10.1016/j.vaccine.2012.03.006
WOS000303302900005.pdf
0264-410X
http://repositorio.unifesp.br/handle/11600/34887
WOS:000303302900005
url http://dx.doi.org/10.1016/j.vaccine.2012.03.006
http://repositorio.unifesp.br/handle/11600/34887
identifier_str_mv Vaccine. Oxford: Elsevier B.V., v. 30, n. 21, p. 3169-3179, 2012.
10.1016/j.vaccine.2012.03.006
WOS000303302900005.pdf
0264-410X
WOS:000303302900005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Vaccine
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
eu_rights_str_mv openAccess
rights_invalid_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.format.none.fl_str_mv 3169-3179
application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268374403776512